327 related articles for article (PubMed ID: 32603415)
21. Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.
Campbell NL; Perkins AJ; Bradt P; Perk S; Wielage RC; Boustani MA; Ng DB
Pharmacotherapy; 2016 Nov; 36(11):1123-1131. PubMed ID: 27711982
[TBL] [Abstract][Full Text] [Related]
22. Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study.
Grossi CM; Richardson K; Fox C; Maidment I; Steel N; Loke YK; Arthur A; Myint PK; Campbell N; Boustani M; Robinson L; Brayne C; Matthews FE; Savva GM
BMC Geriatr; 2019 Oct; 19(1):276. PubMed ID: 31638906
[TBL] [Abstract][Full Text] [Related]
23. Anticholinergic medications and risk of dementia in older adults: Where are we now?
Chatterjee S; Talwar A; Aparasu RR
Expert Opin Drug Saf; 2020 Oct; 19(10):1251-1267. PubMed ID: 32797761
[TBL] [Abstract][Full Text] [Related]
24. Long-term anticholinergic use and the aging brain.
Cai X; Campbell N; Khan B; Callahan C; Boustani M
Alzheimers Dement; 2013 Jul; 9(4):377-85. PubMed ID: 23183138
[TBL] [Abstract][Full Text] [Related]
25. Anticholinergic medications in patients admitted with cognitive impairment or falls (AMiCI). The impact of hospital admission on anticholinergic cognitive medication burden. Results of a multicentre observational study.
Weichert I; Romero-Ortuno R; Tolonen J; Soe T; Lebus C; Choudhury S; Nadarajah CV; Nanayakkara P; Orrù M; Di Somma S;
J Clin Pharm Ther; 2018 Oct; 43(5):682-694. PubMed ID: 29729025
[TBL] [Abstract][Full Text] [Related]
26. Association of Apathy With Risk of Incident Dementia: A Systematic Review and Meta-analysis.
van Dalen JW; van Wanrooij LL; Moll van Charante EP; Brayne C; van Gool WA; Richard E
JAMA Psychiatry; 2018 Oct; 75(10):1012-1021. PubMed ID: 30027214
[TBL] [Abstract][Full Text] [Related]
27. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline.
Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C
J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438
[TBL] [Abstract][Full Text] [Related]
28. Anticholinergic effect on cognition (AEC) of drugs commonly used in older people.
Bishara D; Harwood D; Sauer J; Taylor DM
Int J Geriatr Psychiatry; 2017 Jun; 32(6):650-656. PubMed ID: 27280553
[TBL] [Abstract][Full Text] [Related]
29. Medication Profiles of Patients with Cognitive Impairment and High Anticholinergic Burden.
Green AR; Reifler LM; Boyd CM; Weffald LA; Bayliss EA
Drugs Aging; 2018 Mar; 35(3):223-232. PubMed ID: 29404965
[TBL] [Abstract][Full Text] [Related]
30. Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.
Green AR; Reifler LM; Bayliss EA; Weffald LA; Boyd CM
Drugs Aging; 2019 Mar; 36(3):289-297. PubMed ID: 30652263
[TBL] [Abstract][Full Text] [Related]
31. Long-term anticholinergic, benzodiazepine and Z-drug use in community-dwelling older adults: What is the impact on cognitive and neuropsychological performance?
Dyer AH; Laird E; Hoey L; Hughes CF; McNulty H; Ward M; Strain JJ; Molloy AM; Cunningham C; McCarroll K
Int J Geriatr Psychiatry; 2021 Nov; 36(11):1767-1777. PubMed ID: 34227695
[TBL] [Abstract][Full Text] [Related]
32. Anticholinergic drugs and the risk of dementia: A systematic review and meta-analysis.
Zheng YB; Shi L; Zhu XM; Bao YP; Bai LJ; Li JQ; Liu JJ; Han Y; Shi J; Lu L
Neurosci Biobehav Rev; 2021 Aug; 127():296-306. PubMed ID: 33933505
[TBL] [Abstract][Full Text] [Related]
33. Mild polypharmacy and MCI progression in older adults: the mediation effect of drug-drug interactions.
Trevisan C; Limongi F; Siviero P; Noale M; Cignarella A; Manzato E; Sergi G; Maggi S
Aging Clin Exp Res; 2021 Jan; 33(1):49-56. PubMed ID: 31758500
[TBL] [Abstract][Full Text] [Related]
34. Anticholinergic Burden and Cognition in Older Patients With Schizophrenia.
Tsoutsoulas C; Mulsant BH; Kumar S; Ghazala Z; Voineskos AN; Menon M; Pollock BG; Rajji TK
J Clin Psychiatry; 2017; 78(9):e1284-e1290. PubMed ID: 29188908
[TBL] [Abstract][Full Text] [Related]
35. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study.
Ancelin ML; Artero S; Portet F; Dupuy AM; Touchon J; Ritchie K
BMJ; 2006 Feb; 332(7539):455-9. PubMed ID: 16452102
[TBL] [Abstract][Full Text] [Related]
36. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project.
Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S
Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516
[TBL] [Abstract][Full Text] [Related]
37. Anticholinergic exposure and cognitive decline in older adults: effect of anticholinergic exposure definitions in a 3-year analysis of the multidomain Alzheimer preventive trial (MAPT) study.
Andre L; Gallini A; Montastruc F; Coley N; Montastruc JL; Vellas B; Andrieu S; Gardette V;
Br J Clin Pharmacol; 2019 Jan; 85(1):71-99. PubMed ID: 30098049
[TBL] [Abstract][Full Text] [Related]
38. Association of Subjective Cognitive Decline with Risk of Cognitive Impairment and Dementia: A Systematic Review and Meta-Analysis of Prospective Longitudinal Studies.
Wang XT; Wang ZT; Hu HY; Qu Y; Wang M; Shen XN; Xu W; Dong Q; Tan L; Yu JT
J Prev Alzheimers Dis; 2021; 8(3):277-285. PubMed ID: 34101784
[TBL] [Abstract][Full Text] [Related]
39. Anxiety as a Predictor for Cognitive Decline and Dementia: A Systematic Review and Meta-Analysis.
Gulpers B; Ramakers I; Hamel R; Köhler S; Oude Voshaar R; Verhey F
Am J Geriatr Psychiatry; 2016 Oct; 24(10):823-42. PubMed ID: 27591161
[TBL] [Abstract][Full Text] [Related]
40. Dose response relationship of cumulative anticholinergic exposure with incident dementia: validation study of Korean anticholinergic burden scale.
Suh Y; Ah YM; Han E; Jun K; Hwang S; Choi KH; Lee JY
BMC Geriatr; 2020 Jul; 20(1):265. PubMed ID: 32727410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
